Autoantibodies and other biomarkers - Pathological consequences (1)

Lupus

Volumn 17, Issue 3, 2008, Pages 241-246

  Giles, Ian ^a,c   Putterman, C ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; HUMAN; IMMUNOPATHOGENESIS; LEUKOCYTE ADHERENCE; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ANIMALS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BIOLOGICAL MARKERS; DNA; HUMANS; LAMININ; LUPUS ERYTHEMATOSUS, SYSTEMIC; TOLL-LIKE RECEPTORS;

EID: 42549084763     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307088248     Document Type: Conference Paper

References (33)

1. Miyakis, S, Lockshin, MD, Atsumi, T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. Giles, IP, Haley, JD, Nagl, S, Isenberg, DA, Latchman, DS, Rahman, A. A systematic analysis of sequences of human antiphospholipid and anti-beta2-glycoprotein I antibodies: the importance of somatic mutations and certain sequence motifs. Semin Arthritis Rheum 2003; 32: 246-265.
3. Pierangeli, SS, Liu, X, Espinola, R, et al. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb Haemost 2000; 84: 388-395.
4. Chukwuocha, R, Zhu, M, Cho, C, et al. Molecular and genetic characterizations of five pathogenic and two non-pathogenic monoclonal antiphospholipid antibodies. Mol Immunol 2002; 39: 299-311.
5. Giles, I, Haley, J, Nagl, S, et al. Relative importance of different human aPL derived heavy and light chains in the binding of aPL to cardiolipin. Mol Immunol 2003; 40: 49-60.
6. Giles, I, Lambrianedes, N, Latchman, D, et al. The critical role of arginine residues in the binding of human antiphospholipid antibodies to cardiolipin. Arthritis Res Ther 2005; 7: R47-R56.
7. Giles, I, Lambrianides, N, Pattni, N, et al. Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens. J Immunol 2006; 177: 1729-1736.
8. Giles, I, Liu, X, Newton-West, M, et al. The light chain of a human monoclonal antiphospholipid antibody has a dramatic influence on its functional properties in an in vivo mouse model. Arthritis Rheum 2006; 54: S559.
9. Wakeland, EK, Liu, K, Graham, RR, Behrens, TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001; 15: 397-408.
10. Bygrave, AE, Rose, KL, Cortes-Hernandez, J, et al. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol 2004; 2: E243.
11. Carlucci, F, Cortes-Hernandez, J, Fossati-Jimack, L, et al. Genetic dissection of spontaneous autoimmunity driven by 129-derived chromosome 1 Loci when expressed on C57BL/6 mice. J Immunol 2007; 178: 2352-2360.
12. Chen, C, Nagy, Z, Prak, EL, Weigert, M. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity 1995; 3: 747-755.
13. Prak, EL, Weigert, M. Light chain replacement: a new model for antibody gene rearrangement. J Exp Med 1995; 182: 541-548.
14. Sekiguchi, DR, Jainandunsing, SM, Fields, ML, et al. Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J Immunol 2002; 168: 4142-4153.
15. Ben-Yehuda, A, Rasooly, L, Bar-Tana, R, et al. The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J Autoimmun 1995; 8: 279-291.
16. Amital, H, Heilweil, M, Ulmansky, R, et al. Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol 2005; 175: 5516-5523.
17. Qing, X, Zavadil, J, Crosby, MB, et al. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum 2006; 54: 2198-2210.
18. Boule, MW, Broughton, C, Mackay, F, Akira, S, Marshak-Rothstein, A, Rifkin, IR. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004; 199: 1631-1640.
19. Lau, CM, Broughton, C, Tabor, AS, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/toll-like receptor 7 engagement. J Exp Med. 2005; 202: 1171-1177.
20. Rifkin, IR, Leadbetter, EA, Busconi, L, Viglianti, G, Marshak-Rothstein, A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 2005; 204: 27-42.
21. Christensen, SR, Shupe, J, Nickerson, K, Kashgarian, M, Flavell, RA, Shlomchik, MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006; 25: 417-428.
22. Christensen, SR, Shlomchik, MJ. Regulation of lupus-related autoantibody production and clinical disease by toll-like receptors. Semin Immunol 2007; 19: 11-23.
23. Means, TK, Latz, E, Hayashi, F, Murali, MR, Golenbock, DT, Luster, AD. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005; 115:407-417.
24. Mishra, J, Ma, Q, Kelly, C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006; 21: 856-863.
25. Mishra, J, Mori, K, Ma, Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004; 15: 3073-3082.
26. Mishra, J, Ma, Q, Prada, A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14: 2534-2543.
27. Mishra, J, Mori, K, Ma, Q, Kelly, C, Barasch, J, Devarajan, P. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004; 24: 307-315.
28. Mishra, J, Dent, C, Tarabishi, R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238.
29. Mitsnefes, MM, Kathman, TS, Mishra, J, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2001; 22: 101-108.
30. Mori, K, Lee, HT, Rapoport, D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemiareperfusion injury. J Clin Invest 2005; 115: 610-621.
31. Parikh, CR, Jani, A, Mishra, J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6: 1639-1645.
32. Brunner, HI, Mueller, M, Rutherford, C, et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2577-2584.
33. Pitashny, M, Pressler-Schwartz, N, Qing, X, et al. Urinary lipocalin-2 as a potential biomarker for human lupus nephritis. Arthritis Rheum 2007; 56: 1894-1903.